Sicor Inc.
- Share via
The Irvine specialty pharmaceuticals company posted third-quarter net income of $8.4 million, or 8 cents a share, up from $3 million, or 3 cents a share, for the prior-year period. Revenue rose 29% to $71.7 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
